UK Dementia Research Institute at UCL
In December 2016, it was announced that UCL had been selected as the 'hub' of the new £250m UK Dementia Research Institute (UK DRI), to be led by Professor Bart De Strooper.
The UK DRI is a joint £250m investment into dementia research led by the Medical Research Council (MRC) alongside founding charity partners Alzheimer’s Society and Alzheimer’s Research UK.
The UK DRI will be catalytic in the UK’s research efforts to diagnose, treat, care for and prevent dementias, a group of neurodegenerative disorders which include Alzheimer’s, Parkinson’s, Huntington’s disease and vascular dementia.
It will transform dementias research by connecting researchers working across different disciplines, including those outside of the dementias field, and attracting leading experts from around the UK and the world.
UCL was recognised for its world-class dementias research and state-of-the-art facilities, which will be enhanced through close linkage to a number of regional DRI centres.
The UK DRI
will ultimately operate across a number of UK locations, the hub of the research activities and operational
headquarters are at UCL, embedded
within the UCL Institute of Neurology as an autonomous academic research